Research Updates for Influenza Virus and Vaccine Development
Open Access
- 14 April 2021
- Vol. 9 (4), 383
- https://doi.org/10.3390/vaccines9040383
Abstract
While the scientific community has been focusing on combating novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is responsible for the current COVID-19 pandemic, we also want to draw your attention to this Special Issue of Vaccines entitled “Influenza Virus and Vaccine Development”This publication has 8 references indexed in Scilit:
- Correlation of Influenza B Haemagglutination Inhibiton, Single-Radial Haemolysis and Pseudotype-Based Microneutralisation Assays for Immunogenicity Testing of Seasonal VaccinesVaccines, 2021
- Mass Spectrometric Characterization of Narcolepsy-Associated Pandemic 2009 Influenza VaccinesVaccines, 2020
- Development and Evaluation of Vero Cell-Derived Master Donor Viruses for Influenza Pandemic PreparednessVaccines, 2020
- Genetic Co-Administration of Soluble PD-1 Ectodomains Modifies Immune Responses against Influenza A Virus Induced by DNA VaccinationVaccines, 2020
- Immunogenicity and Protective Efficacy of Influenza A DNA Vaccines Encoding Artificial Antigens Based on Conservative Hemagglutinin Stem Region and M2 Protein in MiceVaccines, 2020
- A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy AdultsVaccines, 2020
- Pandemic Influenza Vaccines: What did We Learn from the 2009 Pandemic and are We Better Prepared Now?Vaccines, 2020
- Recombinant Measles AIK-C Vaccine Strain Expressing Influenza HA ProteinVaccines, 2020